Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/23/2000 | CA2374053A1 Secreted polypeptides and corresponding polynucleotides |
11/23/2000 | CA2374045A1 Compositions isolated from skin cells and methods for their use |
11/23/2000 | CA2374015A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme |
11/23/2000 | CA2374013A1 Protein a based binding domains with desirable activities |
11/23/2000 | CA2373616A1 Tm4sf receptors |
11/23/2000 | CA2373231A1 Extracellular signaling molecules |
11/23/2000 | CA2373191A1 Full-length molecules expressed in human tissues |
11/23/2000 | CA2372926A1 143 human secreted proteins |
11/23/2000 | CA2372794A1 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
11/23/2000 | CA2372661A1 Cdx2 is downstream mediator of apc tumor suppressor activity |
11/23/2000 | CA2372654A1 Acquired resistance genes in plants |
11/23/2000 | CA2372556A1 Directed evolution of microorganisms |
11/23/2000 | CA2372549A1 Ox2 receptor homologs |
11/23/2000 | CA2372435A1 Recombinant human mannan-binding lectin |
11/23/2000 | CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes |
11/23/2000 | CA2372338A1 Long lasting fusion peptide inhibitors of viral infection |
11/23/2000 | CA2372323A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
11/23/2000 | CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
11/23/2000 | CA2372200A1 Self-assembling biomolecular structures |
11/23/2000 | CA2372199A1 Oligomeric chaperone proteins |
11/23/2000 | CA2372198A1 Protein scaffold and its use to multimerise monomeric polypeptides |
11/23/2000 | CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
11/23/2000 | CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily |
11/23/2000 | CA2372105A1 Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2371245A1 Crystal structure of ribosomal protein l11/gtpase activating region rrna and uses thereof |
11/23/2000 | CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
11/23/2000 | CA2369085A1 Ex vivo expansion of mammalian hematopoietic stem cells |
11/23/2000 | CA2368833A1 Molecules expressed in hippocampus |
11/23/2000 | CA2368608A1 Transgenically produced antithrombin iii and mutants thereof |
11/22/2000 | EP1054064A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
11/22/2000 | EP1054063A2 Process for the production of naturally folded and secreted proteins |
11/22/2000 | EP1054061A1 Protein standard, comprising at least one antibody-binding domain of streptococcal protein G |
11/22/2000 | EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation |
11/22/2000 | EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents |
11/22/2000 | EP1053677A1 Nonhuman animal embryonic stem cells and nonhuman animals having variant smooth muscle myosin heavy-chain genes |
11/22/2000 | EP1053358A1 The use of hiv-1 integrase in screening hiv-1 drug candidates |
11/22/2000 | EP1053355A2 Pna and dna conjugates and methods for preparation thereof |
11/22/2000 | EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor |
11/22/2000 | EP1053343A2 Targeting of genetic vaccine vectors |
11/22/2000 | EP1053342A2 Nucleic acid delivery vehicles |
11/22/2000 | EP1053338A1 Alteration of amino acid compositions in seeds |
11/22/2000 | EP1053337A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase |
11/22/2000 | EP1053336A1 Promoter inductible in plants, sequence incorporating same and resulting product |
11/22/2000 | EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
11/22/2000 | EP1053331A2 A novel fungal protein critical for expression of fungal proteins |
11/22/2000 | EP1053330A2 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
11/22/2000 | EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE |
11/22/2000 | EP1053328A2 Plant having altered environmental stress tolerance |
11/22/2000 | EP1053327A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof |
11/22/2000 | EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
11/22/2000 | EP1053324A1 Novel cystine knot protein and materials and methods for making it |
11/22/2000 | EP1053323A2 Human receptor proteins |
11/22/2000 | EP1053322A1 Wnt-10a |
11/22/2000 | EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
11/22/2000 | EP1053320A2 Human transport-associated molecules |
11/22/2000 | EP1053319A2 Human genes and gene expression products ii |
11/22/2000 | EP1053318A2 Cdnas encoding secreted proteins |
11/22/2000 | EP1053315A1 Human hairless gene, protein and uses thereof |
11/22/2000 | EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines |
11/22/2000 | EP1053310A1 Cold-shock regulatory elements, constructs thereof, and methods of use |
11/22/2000 | EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule |
11/22/2000 | EP1053307A1 Podocalyxin like sialomucins having selectin ligand activity |
11/22/2000 | EP1053306A1 Secreted proteins and polynucleotides encoding them |
11/22/2000 | EP1053255A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF |
11/22/2000 | EP1053254A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
11/22/2000 | EP1053253A1 Novel gaba b? receptor dna sequences |
11/22/2000 | EP1053252A1 Secreted proteins and polynucleotides encoding them |
11/22/2000 | EP1053251A1 The aiolos gene |
11/22/2000 | EP1053249A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production |
11/22/2000 | EP1053248A1 Peptide structures and their use in diagnosis of herpes simplex virus type 2 |
11/22/2000 | EP1053245A1 45 human secreted proteins |
11/22/2000 | EP1053024A1 Liposome fusion and delivery vehicle |
11/22/2000 | EP1053017A2 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
11/22/2000 | EP1053014A1 BIOLOGICALLY ACTIVE HEMAGGLUTININ FROM TYPE A $i(CLOSTRIDIUM BOTULINUM) AND METHODS OF USE |
11/22/2000 | EP1053013A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob |
11/22/2000 | EP1053009A2 Use of heregulin as an epithelial cell growth factor |
11/22/2000 | EP1053007A2 Methods and compositions for modulating leptin activity |
11/22/2000 | EP1053002A1 Treatment of bony defects with osteoblast precursor cells |
11/22/2000 | EP1053001A1 Novel mixed amylin activity compounds |
11/22/2000 | EP1018875A4 Insecticidal peptides from segestria sp. spider venom |
11/22/2000 | EP0971580A4 Regulatory element for expressing genes in plants |
11/22/2000 | EP0871885A4 Attachment enhanced 293 cells |
11/22/2000 | EP0866717A4 Oligodendrocyte-specific protein and method for treating disease |
11/22/2000 | EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels |
11/22/2000 | EP0703988B1 Mesothelial cell gene therapy |
11/22/2000 | CN1274387A HCVE mimotopes of hypervariable region 1 and uses |
11/22/2000 | CN1274386A Genetic control of plant growth and develepmnt |
11/22/2000 | CN1274289A Compsns. comprising comjugates of stable, active, human ob protein with antibody FC chain and methods |
11/22/2000 | CN1274260A Hypersensitive response elicitor from i(Erwinia Amylovora) and its use |
11/22/2000 | CN1274259A Hypersensitive response elicitor from i(pseudomonas syringae) and its use |
11/22/2000 | CN1274008A Exoteric expression of hay bacillus cecropi and its method |
11/22/2000 | CN1273976A Process for preparing recombined morphogenetic protein (rhOP-1) of human bone |
11/21/2000 | US6150589 Genes encoding lepidopteran-active toxins from Bacillus thuringiensis isolate PS158C2 |
11/21/2000 | US6150588 DNA encoding antimicrobial proteins from impatiens |
11/21/2000 | US6150585 Recombinant dna constructs of dna sequence which encodes an defined rna sequence under control of promoter and terminator; transgenic, disease resistant plants |
11/21/2000 | US6150583 Transgenic animals expressing artificial epitope-tagged proteins |
11/21/2000 | US6150547 Iron-casein complex hydrolyzate and process for the production thereof |